Market Research Logo

Dermatology Therapeutics Drug Development Pipeline Review, 2016

Dermatology Therapeutics Drug Development Pipeline Review, 2016

Summary


Dermatological conditions are one of the most common types of disorders worldwide, and approximately one-third of the US population suffers from at least one active skin condition. For the past decades, the majority of the dermatology market has remained saturated with established and generic products. However, the clinical and commercial success of biologics in the treatment of psoriasis, as well as advancements in the understanding of the disease pathways of many dermatological conditions, have led to a renewed interest from pharmaceutical companies in the dermatology market, and subsequently the emergence of an innovative pipeline.

There are over 800 products in active development in the dermatology therapy area, with the majority of products being small molecules. Biologics represent approximately 40% of the pipeline, despite the fact that this molecule type represents only a small fraction of the marketed products landscape.

Overall, the dermatology pipeline is highly innovative, owing to the advancements in the understanding of the disease pathways of many skin disorders. The number of strong late-stage products and substantial early-stage segment of this active and diverse pipeline are strong indicators of long-term growth in this market.

The report provides comprehensive information on the pipeline development landscape for is Acne vulgaris, Psoriasis and Atopic dermatitis, from Discovery through to the Pre-Registration stage. This includes an analysis of products by stage of development, molecular target, mechanism of action (MoA), route of administration (RoA) and molecule type. A list of all products in development is provided, including dormant and discontinued projects. Finally, the report provides an overview of key players involved in the development of products in this area, and outlines recent updates and press releases in the field.

Scope

  • Which companies are the most active within the pipeline for dermatology?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened in this disease area?
Reasons to buy
  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration


  • Executive Summary
  • Introduction
    • GBI Research Report Coverage
    • Acne Vulgaris Overview
    • Psoriasis Overview
    • Atopic Dermatitis Overview
  • Therapeutics Development
    • Acne Vulgaris
      • Pipeline Products for Acne Vulgaris - Overview
        • Table Figure 1: Number of Products under Development for Acne Vulgaris,
        • Table Number of Products under Development for Acne Vulgaris,
      • Pipeline Products for Acne Vulgaris - Comparative Analysis
        • Table Figure 2: Number of Products under Development for Acne Vulgaris - Comparative Analysis,
        • Table Number of Products under Development for Acne Vulgaris - Comparative Analysis,
    • Psoriasis
      • Pipeline Products for Psoriasis - Overview
        • Table Figure 3: Number of Products under Development for Psoriasis,
        • Table Number of Products under Development for Psoriasis,
      • Pipeline Products for Psoriasis - Comparative Analysis
        • Table Figure 4: Number of Products under Development for Psoriasis - Comparative Analysis,
        • Table Number of Products under Development for Psoriasis - Comparative Analysis,
    • Atopic Dermatitis
      • Pipeline Products for Atopic Dermatitis - Overview
        • Table Figure 5: Number of Products under Development for Atopic Dermatitis,
        • Table Number of Products under Development for Atopic Dermatitis,
      • Pipeline Products for Atopic Dermatitis - Comparative Analysis
        • Table Figure 6: Number of Products under Development for Atopic Dermatitis - Comparative Analysis,
        • Table Number of Products under Development for Atopic Dermatitis - Comparative Analysis,
  • Therapeutics under Development by Companies
    • Acne Vulgaris
      • Table Figure 7: Number of Products under Development by Companies - Acne Vulgaris
      • Table Number of Products under Development by Companies - Acne Vulgaris
    • Psoriasis
      • Table Figure 8: Number of Products under Development by Companies – Psoriasis
      • Table Number of Products under Development by Companies - Psoriasis
    • Atopic Dermatitis
      • Table Figure 9: Number of Products under Development by Companies - Atopic Dermatitis
      • Table Number of Products under Development by Companies - Atopic Dermatitis
  • Therapeutics under Investigation by Universities/Institutes
    • Acne Vulgaris
      • Table Figure 10: Number of Products under Investigation by Universities/Institutes - Acne Vulgaris
      • Table Number of Products under Investigation by Universities/Institutes - Acne Vulgaris
    • Psoriasis
      • Table Figure 11: Number of Products under Investigation by Universities/Institutes – Psoriasis
      • Table Number of Products under Investigation by Universities/Institutes - Psoriasis
    • Atopic Dermatitis
      • Table Figure 12: Number of Products under Investigation by Universities/Institutes - Atopic Dermatitis
      • Table Number of Products under Investigation by Universities/Institutes - Atopic Dermatitis
  • Pipeline Products Glance
    • Acne Vulgaris
      • Late Stage Products
        • Table Figure 13: Comparative Analysis by Late Stage Development - Acne Vulgaris
        • Table Comparative Analysis by Late Stage Development - Acne Vulgaris
      • Clinical Stage Products
        • Table Figure 14: Comparative Analysis by Clinical Stage Development - Acne Vulgaris
        • Table Comparative Analysis by Clinical Stage Development - Acne Vulgaris
      • Early Stage Products
        • Table Figure 15: Comparative Analysis by Early Stage Products - Acne Vulgaris
        • Table Comparative Analysis by Early Stage Development - Acne Vulgaris
    • Psoriasis
      • Late Stage Products
        • Table Figure 16: Comparative Analysis by Late Stage Development – Psoriasis
        • Table Comparative Analysis by Late Stage Development - Psoriasis
      • Clinical Stage Products
        • Table Figure 17: Comparative Analysis by Clinical Stage Development – Psoriasis
        • Table Comparative Analysis by Clinical Stage Development - Psoriasis
      • Early Stage Products
        • Table Figure 18: Comparative Analysis by Early Stage Products – Psoriasis
        • Table Comparative Analysis by Early Stage Development - Psoriasis
      • Unknown Stage Products
        • Table Comparative Analysis by Unknown Stage Development - Psoriasis
    • Atopic Dermatitis
      • Late Stage Products
        • Table Figure 19: Comparative Analysis by Late Stage Development - Atopic Dermatitis
        • Table Comparative Analysis by Late Stage Development - Atopic Dermatitis
      • Clinical Stage Products
        • Table Figure 20: Comparative Analysis by Clinical Stage Development - Atopic Dermatitis
        • Table Comparative Analysis by Clinical Stage Development - Atopic Dermatitis
      • Early Stage Products
        • Table Figure 21: Comparative Analysis by Early Stage Products - Atopic Dermatitis
        • Table Comparative Analysis by Early Stage Development - Atopic Dermatitis
  • Products under Development by Companies
    • Acne Vulgaris
      • Table Products under Development by Companies
    • Psoriasis
      • Table Products under Development by Companies - Psoriasis
    • Atopic Dermatitis
      • Table Products under Development by Companies,
  • Products under Investigation by Universities/Institutes
    • Acne Vulgaris
      • Table Products under Investigation by Universities/Institutes - Acne Vulgaris
    • Psoriasis
      • Table Products under Investigation by Universities/Institutes - Psoriasis
    • Atopic Dermatitis
      • Table Products under Investigation by Universities/Institutes - Atopic Dermatitis
  • Companies Involved in Therapeutics Development
    • Acne Vulgaris
      • 3SBio Inc
        • Table Acne Vulgaris - Pipeline by 3SBio Inc,
      • Allergan Plc
        • Table Acne Vulgaris - Pipeline by Allergan Plc,
      • Almirall SA
        • Table Acne Vulgaris - Pipeline by Almirall SA,
      • Antibiotx ApS
        • Table Acne Vulgaris - Pipeline by Antibiotx ApS,
      • Biomar Microbial Technologies
        • Table Acne Vulgaris - Pipeline by Biomar Microbial Technologies,
      • BioPharmX Inc
        • Table Acne Vulgaris - Pipeline by BioPharmX Inc,
      • Braintree Laboratories Inc
        • Table Acne Vulgaris - Pipeline by Braintree Laboratories Inc,
      • Brickell Biotech Inc
        • Table Acne Vulgaris - Pipeline by Brickell Biotech Inc,
      • Cell Medica Ltd
        • Table Acne Vulgaris - Pipeline by Cell Medica Ltd,
      • Cellceutix Corp
        • Table Acne Vulgaris - Pipeline by Cellceutix Corp,
      • Celtaxsys Inc
        • Table Acne Vulgaris - Pipeline by Celtaxsys Inc,
      • Common Pharma Inc
        • Table Acne Vulgaris - Pipeline by Common Pharma Inc,
      • Cutanea Life Sciences Inc
        • Table Acne Vulgaris - Pipeline by Cutanea Life Sciences Inc,
      • DermaXon LLC
        • Table Acne Vulgaris - Pipeline by DermaXon LLC,
      • Dermira Inc
        • Table Acne Vulgaris - Pipeline by Dermira Inc,
      • ELORAC Inc
        • Table Acne Vulgaris - Pipeline by ELORAC Inc,
      • Ensol Biosciences Inc
        • Table Acne Vulgaris - Pipeline by Ensol Biosciences Inc,
      • Foamix Pharmaceuticals Ltd
        • Table Acne Vulgaris - Pipeline by Foamix Pharmaceuticals Ltd,
      • Galderma SA
        • Table Acne Vulgaris - Pipeline by Galderma SA,
      • GlaxoSmithKline Plc
        • Table Acne Vulgaris - Pipeline by GlaxoSmithKline Plc,
      • Helix BioMedix Inc
        • Table Acne Vulgaris - Pipeline by Helix BioMedix Inc,
      • Hovione FarmaCiencia SA
        • Table Acne Vulgaris - Pipeline by Hovione FarmaCiencia SA,
      • Lee's Pharmaceutical Holdings Ltd
        • Table Acne Vulgaris - Pipeline by Lee's Pharmaceutical Holdings Ltd,
      • LEO Pharma A/S
        • Table Acne Vulgaris - Pipeline by LEO Pharma A/S,
      • Novabiotics Ltd
        • Table Acne Vulgaris - Pipeline by Novabiotics Ltd,
      • Novan Inc
        • Table Acne Vulgaris - Pipeline by Novan Inc,
      • Paratek Pharmaceuticals Inc
        • Table Acne Vulgaris - Pipeline by Paratek Pharmaceuticals Inc,
      • Pfizer Inc
        • Table Acne Vulgaris - Pipeline by Pfizer Inc,
      • Phosphagenics Ltd
        • Table Acne Vulgaris - Pipeline by Phosphagenics Ltd,
      • Photocure ASA
        • Table Acne Vulgaris - Pipeline by Photocure ASA,
      • Promius Pharma LLC
        • Table Acne Vulgaris - Pipeline by Promius Pharma LLC,
      • Provectus Biopharmaceuticals Inc
        • Table Acne Vulgaris - Pipeline by Provectus Biopharmaceuticals Inc,
      • Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
        • Table Acne Vulgaris - Pipeline by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd,
      • Sol-Gel Technologies Ltd
        • Table Acne Vulgaris - Pipeline by Sol-Gel Technologies Ltd,
      • Sun Pharma Advanced Research Company Ltd
        • Table Acne Vulgaris - Pipeline by Sun Pharma Advanced Research Company Ltd,
      • Telesso Technologies Ltd
        • Table Acne Vulgaris - Pipeline by Telesso Technologies Ltd,
      • Thesan Pharmaceuticals Inc
        • Table Acne Vulgaris - Pipeline by Thesan Pharmaceuticals Inc,
      • Valeant Pharmaceuticals International Inc
        • Table Acne Vulgaris - Pipeline by Valeant Pharmaceuticals International Inc,
      • Vectura Group Plc
        • Table Acne Vulgaris - Pipeline by Vectura Group Plc,
      • Vyome Biosciences Pvt Ltd
        • Table Acne Vulgaris - Pipeline by Vyome Biosciences Pvt Ltd,
      • XBiotech Inc
        • Table Acne Vulgaris - Pipeline by XBiotech Inc,
      • Xenon Pharmaceuticals Inc
        • Table Acne Vulgaris - Pipeline by Xenon Pharmaceuticals Inc,
    • Psoriasis
      • AbbVie Inc
        • Table Psoriasis - Pipeline by AbbVie Inc,
      • Abeome Corp
        • Table Psoriasis - Pipeline by Abeome Corp,
      • AbGenomics International Inc
        • Table Psoriasis - Pipeline by AbGenomics International Inc,
      • Addex Therapeutics Ltd
        • Table Psoriasis - Pipeline by Addex Therapeutics Ltd,
      • Adello Biologics LLC
        • Table Psoriasis - Pipeline by Adello Biologics LLC,
      • Advinus Therapeutics Ltd
        • Table Psoriasis - Pipeline by Advinus Therapeutics Ltd,
      • Affibody AB
        • Table Psoriasis - Pipeline by Affibody AB,
      • Albireo Pharma Inc
        • Table Psoriasis - Pipeline by Albireo Pharma Inc,
      • Alfacyte Ltd
        • Table Psoriasis - Pipeline by Alfacyte Ltd,
      • Almirall SA
        • Table Psoriasis - Pipeline by Almirall SA,
      • Alteogen Inc
        • Table Psoriasis - Pipeline by Alteogen Inc,
      • Amgen Inc
        • Table Psoriasis - Pipeline by Amgen Inc,
      • Anacor Pharmaceuticals Inc
        • Table Psoriasis - Pipeline by Anacor Pharmaceuticals Inc,
      • AnaptysBio Inc
        • Table Psoriasis - Pipeline by AnaptysBio Inc,
      • ApoPharma Inc
        • Table Psoriasis - Pipeline by ApoPharma Inc,
      • Arena Pharmaceuticals Inc
        • Table Psoriasis - Pipeline by Arena Pharmaceuticals Inc,
      • Argos Therapeutics Inc
        • Table Psoriasis - Pipeline by Argos Therapeutics Inc,
      • Arrien Pharmaceuticals LLC
        • Table Psoriasis - Pipeline by Arrien Pharmaceuticals LLC,
      • AstraZeneca Plc
        • Table Psoriasis - Pipeline by AstraZeneca Plc,
      • Athenex Inc
        • Table Psoriasis - Pipeline by Athenex Inc,
      • Atlantic Bio Sci LLC
        • Table Psoriasis - Pipeline by Atlantic Bio Sci LLC,
      • Aurigene Discovery Technologies Ltd
        • Table Psoriasis - Pipeline by Aurigene Discovery Technologies Ltd,
      • Aurinia Pharmaceuticals Inc
        • Table Psoriasis - Pipeline by Aurinia Pharmaceuticals Inc,
      • Avexxin AS
        • Table Psoriasis - Pipeline by Avexxin AS,
      • Bayer AG
        • Table Psoriasis - Pipeline by Bayer AG,
      • Betta Pharmaceuticals Co Ltd
        • Table Psoriasis - Pipeline by Betta Pharmaceuticals Co Ltd,
      • BioApex sro
        • Table Psoriasis - Pipeline by BioApex sro,
      • Biocad
        • Table Psoriasis - Pipeline by Biocad,
      • Biocon Ltd
        • Table Psoriasis - Pipeline by Biocon Ltd,
      • BioLingus AG
        • Table Psoriasis - Pipeline by BioLingus AG,
      • BioMAS Ltd
        • Table Psoriasis - Pipeline by BioMAS Ltd,
      • Biomics Biotechnologies Co Ltd
        • Table Psoriasis - Pipeline by Biomics Biotechnologies Co Ltd,
      • Bionomics Ltd
        • Table Psoriasis - Pipeline by Bionomics Ltd,
      • Bionovis SA
        • Table Psoriasis - Pipeline by Bionovis SA,
      • BirchBioMed Inc
        • Table Psoriasis - Pipeline by BirchBioMed Inc,
      • Boehringer Ingelheim GmbH
        • Table Psoriasis - Pipeline by Boehringer Ingelheim GmbH,
      • Brickell Biotech Inc
        • Table Psoriasis - Pipeline by Brickell Biotech Inc,
      • Bristol-Myers Squibb Company
        • Table Psoriasis - Pipeline by Bristol-Myers Squibb Company,
      • C4X Discovery Holdings PLC
        • Table Psoriasis - Pipeline by C4X Discovery Holdings PLC,
      • CalciMedica Inc
        • Table Psoriasis - Pipeline by CalciMedica Inc,
      • Can-Fite BioPharma Ltd
        • Table Psoriasis - Pipeline by Can-Fite BioPharma Ltd,
      • Celgene Corp
        • Table Psoriasis - Pipeline by Celgene Corp,
      • Cell Medica Ltd
        • Table Psoriasis - Pipeline by Cell Medica Ltd,
      • Cellceutix Corp
        • Table Psoriasis - Pipeline by Cellceutix Corp,
      • ChemoCentryx Inc
        • Table Psoriasis - Pipeline by ChemoCentryx Inc,
      • Chipscreen Biosciences Ltd
        • Table Psoriasis - Pipeline by Chipscreen Biosciences Ltd,
      • ChironWells GmbH
        • Table Psoriasis - Pipeline by ChironWells GmbH,
      • Coherus BioSciences Inc
        • Table Psoriasis - Pipeline by Coherus BioSciences Inc,
      • Compugen Ltd
        • Table Psoriasis - Pipeline by Compugen Ltd,
      • Convoy Therapeutics Inc
        • Table Psoriasis - Pipeline by Convoy Therapeutics Inc,
      • Creabilis SA
        • Table Psoriasis - Pipeline by Creabilis SA,
      • Crescendo Biologics Ltd
        • Table Psoriasis - Pipeline by Crescendo Biologics Ltd,
      • Curapel Ltd
        • Table Psoriasis - Pipeline by Curapel Ltd,
      • Cutanea Life Sciences Inc
        • Table Psoriasis - Pipeline by Cutanea Life Sciences Inc,
      • Dermala Inc
        • Table Psoriasis - Pipeline by Dermala Inc,
      • Domainex Ltd
        • Table Psoriasis - Pipeline by Domainex Ltd,
      • Dr. August Wolff GmbH & Co KG Arzneimittle
        • Table Psoriasis - Pipeline by Dr. August Wolff GmbH & Co KG Arzneimittle,
      • EA Pharma Co Ltd
        • Table Psoriasis - Pipeline by EA Pharma Co Ltd,
      • Eli Lilly and Company
        • Table Psoriasis - Pipeline by Eli Lilly and Company,
      • ELORAC Inc
        • Table Psoriasis - Pipeline by ELORAC Inc,
      • Exicure Inc
        • Table Psoriasis - Pipeline by Exicure Inc,
      • Foamix Pharmaceuticals Ltd
        • Table Psoriasis - Pipeline by Foamix Pharmaceuticals Ltd,
      • Forward Pharma A/S
        • Table Psoriasis - Pipeline by Forward Pharma A/S,
      • Gem Pharmaceuticals LLC
        • Table Psoriasis - Pipeline by Gem Pharmaceuticals LLC,
      • Genentech Inc
        • Table Psoriasis - Pipeline by Genentech Inc,
      • Genor BioPharma Co Ltd
        • Table Psoriasis - Pipeline by Genor BioPharma Co Ltd,
      • GlaxoSmithKline Plc
        • Table Psoriasis - Pipeline by GlaxoSmithKline Plc,
      • GlycoMar Ltd
        • Table Psoriasis - Pipeline by GlycoMar Ltd,
      • Grupo Ferrer Internacional SA
        • Table Psoriasis - Pipeline by Grupo Ferrer Internacional SA,
      • HitGen LTD
        • Table Psoriasis - Pipeline by HitGen LTD,
      • Huabo Biopharm Co Ltd
        • Table Psoriasis - Pipeline by Huabo Biopharm Co Ltd,
      • Hydra Biosciences Inc
        • Table Psoriasis - Pipeline by Hydra Biosciences Inc,
      • iCo Therapeutics Inc.
        • Table Psoriasis - Pipeline by iCo Therapeutics Inc.,
      • Idera Pharmaceuticals Inc
        • Table Psoriasis - Pipeline by Idera Pharmaceuticals Inc,
      • Iltoo Pharma
        • Table Psoriasis - Pipeline by Iltoo Pharma,
      • Immune Pharmaceuticals Inc
        • Table Psoriasis - Pipeline by Immune Pharmaceuticals Inc,
      • Immune Response BioPharma Inc
        • Table Psoriasis - Pipeline by Immune Response BioPharma Inc,
      • Immungenetics AG
        • Table Psoriasis - Pipeline by Immungenetics AG,
      • Innovent Biologics Inc
        • Table Psoriasis - Pipeline by Innovent Biologics Inc,
      • Jenrin Discovery Inc
        • Table Psoriasis - Pipeline by Jenrin Discovery Inc,
      • Jiangsu Hengrui Medicine Co Ltd
        • Table Psoriasis - Pipeline by Jiangsu Hengrui Medicine Co Ltd,
      • Johnson & Johnson
        • Table Psoriasis - Pipeline by Johnson & Johnson,
      • Kadmon Corp LLC
        • Table Psoriasis - Pipeline by Kadmon Corp LLC,
      • KaloBios Pharmaceuticals Inc
        • Table Psoriasis - Pipeline by KaloBios Pharmaceuticals Inc,
      • Kang Stem Biotech Co Ltd
        • Table Psoriasis - Pipeline by Kang Stem Biotech Co Ltd,
      • KPI Therapeutics Inc
        • Table Psoriasis - Pipeline by KPI Therapeutics Inc,
      • Lead Pharma Holding BV
        • Table Psoriasis - Pipeline by Lead Pharma Holding BV,
      • Lee's Pharmaceutical Holdings Ltd
        • Table Psoriasis - Pipeline by Lee's Pharmaceutical Holdings Ltd,
      • LEO Pharma A/S
        • Table Psoriasis - Pipeline by LEO Pharma A/S,
      • Lipidor AB
        • Table Psoriasis - Pipeline by Lipidor AB,
      • Lupin Ltd
        • Table Psoriasis - Pipeline by Lupin Ltd,
      • Lycera Corp
        • Table Psoriasis - Pipeline by Lycera Corp,
      • mAbxience SA
        • Table Psoriasis - Pipeline by mAbxience SA,
      • Maruho Co Ltd
        • Table Psoriasis - Pipeline by Maruho Co Ltd,
      • Medestea Research & Production SpA
        • Table Psoriasis - Pipeline by Medestea Research & Production SpA,
      • MediGene AG
        • Table Psoriasis - Pipeline by MediGene AG,
      • Merck KGaA
        • Table Psoriasis - Pipeline by Merck KGaA,
      • MetrioPharm AG
        • Table Psoriasis - Pipeline by MetrioPharm AG,
      • Mitsubishi Tanabe Pharma Corp
        • Table Psoriasis - Pipeline by Mitsubishi Tanabe Pharma Corp,
      • Momenta Pharmaceuticals Inc
        • Table Psoriasis - Pipeline by Momenta Pharmaceuticals Inc,
      • Mycenax Biotech Inc
        • Table Psoriasis - Pipeline by Mycenax Biotech Inc,
      • NeuClone Pty Ltd
        • Table Psoriasis - Pipeline by NeuClone Pty Ltd,
      • Nimbus Therapeutics LLC
        • Table Psoriasis - Pipeline by Nimbus Therapeutics LLC,
      • NovaLead Pharma Pvt Ltd
        • Table Psoriasis - Pipeline by NovaLead Pharma Pvt Ltd,
      • Novan Inc
        • Table Psoriasis - Pipeline by Novan Inc,
      • Novartis AG
        • Table Psoriasis - Pipeline by Novartis AG,
      • Nuevolution AB
        • Table Psoriasis - Pipeline by Nuevolution AB,
      • Numedii Inc
        • Table Psoriasis - Pipeline by Numedii Inc,
      • Oncobiologics Inc
        • Table Psoriasis - Pipeline by Oncobiologics Inc,
      • OSE Immunotherapeutics
        • Table Psoriasis - Pipeline by OSE Immunotherapeutics,
      • Panacea Biotec Ltd
        • Table Psoriasis - Pipeline by Panacea Biotec Ltd,
      • Pfizer Inc
        • Table Psoriasis - Pipeline by Pfizer Inc,
      • Pharis Biotec GmbH
        • Table Psoriasis - Pipeline by Pharis Biotec GmbH,
      • Pharmedartis GmbH
        • Table Psoriasis - Pipeline by Pharmedartis GmbH,
      • Pieris Pharmaceuticals Inc
        • Table Psoriasis - Pipeline by Pieris Pharmaceuticals Inc,
      • PinCell srl
        • Table Psoriasis - Pipeline by PinCell srl,
      • Promius Pharma LLC
        • Table Psoriasis - Pipeline by Promius Pharma LLC,
      • Protalix BioTherapeutics Inc
        • Table Psoriasis - Pipeline by Protalix BioTherapeutics Inc,
      • Prothena Corp Plc
        • Table Psoriasis - Pipeline by Prothena Corp Plc,
      • Provectus Biopharmaceuticals Inc
        • Table Psoriasis - Pipeline by Provectus Biopharmaceuticals Inc,
      • RedHill Biopharma Ltd
        • Table Psoriasis - Pipeline by RedHill Biopharma Ltd,
      • Reliance Life Sciences Pvt Ltd
        • Table Psoriasis - Pipeline by Reliance Life Sciences Pvt Ltd,
      • Samumed LLC
        • Table Psoriasis - Pipeline by Samumed LLC,
      • Sandoz International GmbH
        • Table Psoriasis - Pipeline by Sandoz International GmbH,
      • Sareum Holdings Plc
        • Table Psoriasis - Pipeline by Sareum Holdings Plc,
      • Selvita SA
        • Table Psoriasis - Pipeline by Selvita SA,
      • Shanghai Celgen Bio-Pharmaceutical Co Ltd
        • Table Psoriasis - Pipeline by Shanghai Celgen Bio-Pharmaceutical Co Ltd,
      • Shulov Innovative Science Ltd
        • Table Psoriasis - Pipeline by Shulov Innovative Science Ltd,
      • Sigmoid Pharma Ltd
        • Table Psoriasis - Pipeline by Sigmoid Pharma Ltd,
      • Soligenix Inc
        • Table Psoriasis - Pipeline by Soligenix Inc,
      • Spherium Biomed SL
        • Table Psoriasis - Pipeline by Spherium Biomed SL,
      • Stemline Therapeutics Inc
        • Table Psoriasis - Pipeline by Stemline Therapeutics Inc,
      • sterna biologicals Gmbh & Co KG
        • Table Psoriasis - Pipeline by sterna biologicals Gmbh & Co KG,
      • Sucampo Pharmaceuticals Inc
        • Table Psoriasis - Pipeline by Sucampo Pharmaceuticals Inc,
      • Sun Pharma Advanced Research Company Ltd
        • Table Psoriasis - Pipeline by Sun Pharma Advanced Research Company Ltd,
      • SWITCH Biotech LLC
        • Table Psoriasis - Pipeline by SWITCH Biotech LLC,
      • Takeda Pharmaceutical Company Ltd
        • Table Psoriasis - Pipeline by Takeda Pharmaceutical Company Ltd,
      • Tasly Pharmaceutical Group Co Ltd
        • Table Psoriasis - Pipeline by Tasly Pharmaceutical Group Co Ltd,
      • Telormedix SA
        • Table Psoriasis - Pipeline by Telormedix SA,
      • Teva Pharmaceutical Industries Ltd
        • Table Psoriasis - Pipeline by Teva Pharmaceutical Industries Ltd,
      • TheraMAB LLC
        • Table Psoriasis - Pipeline by TheraMAB LLC,
      • Therapix Biosciences Ltd
        • Table Psoriasis - Pipeline by Therapix Biosciences Ltd,
      • UCB SA
        • Table Psoriasis - Pipeline by UCB SA,
      • Valeant Pharmaceuticals International Inc
        • Table Psoriasis - Pipeline by Valeant Pharmaceuticals International Inc,
      • Vitae Pharmaceuticals Inc
        • Table Psoriasis - Pipeline by Vitae Pharmaceuticals Inc,
      • Wellstat Therapeutics Corp
        • Table Psoriasis - Pipeline by Wellstat Therapeutics Corp,
      • XBiotech Inc
        • Table Psoriasis - Pipeline by XBiotech Inc,
      • XenoPort Inc
        • Table Psoriasis - Pipeline by XenoPort Inc,
      • Yuhan Corp
        • Table Psoriasis - Pipeline by Yuhan Corp,
      • Ziarco Pharma Ltd
        • Table Psoriasis - Pipeline by Ziarco Pharma Ltd,
    • Atopic Dermatitis
      • AbbVie Inc
        • Table Atopic Dermatitis - Pipeline by AbbVie Inc,
      • Abeome Corp
        • Table Atopic Dermatitis - Pipeline by Abeome Corp,
      • Accolade Pharmaceuticals LLC
        • Table Atopic Dermatitis - Pipeline by Accolade Pharmaceuticals LLC,
      • Albireo Pharma Inc
        • Table Atopic Dermatitis - Pipeline by Albireo Pharma Inc,
      • Almirall SA
        • Table Atopic Dermatitis - Pipeline by Almirall SA,
      • Amgen Inc
        • Table Atopic Dermatitis - Pipeline by Amgen Inc,
      • Amorepacific Corp
        • Table Atopic Dermatitis - Pipeline by Amorepacific Corp,
      • Anacor Pharmaceuticals Inc
        • Table Atopic Dermatitis - Pipeline by Anacor Pharmaceuticals Inc,
      • AnaMar AB
        • Table Atopic Dermatitis - Pipeline by AnaMar AB,
      • AnaptysBio Inc
        • Table Atopic Dermatitis - Pipeline by AnaptysBio Inc,
      • AnGes MG Inc
        • Table Atopic Dermatitis - Pipeline by AnGes MG Inc,
      • Avexxin AS
        • Table Atopic Dermatitis - Pipeline by Avexxin AS,
      • Blueberry Therapeutics Ltd
        • Table Atopic Dermatitis - Pipeline by Blueberry Therapeutics Ltd,
      • Brickell Biotech Inc
        • Table Atopic Dermatitis - Pipeline by Brickell Biotech Inc,
      • Celgene Corp
        • Table Atopic Dermatitis - Pipeline by Celgene Corp,
      • Cell Medica Ltd
        • Table Atopic Dermatitis - Pipeline by Cell Medica Ltd,
      • Cellceutix Corp
        • Table Atopic Dermatitis - Pipeline by Cellceutix Corp,
      • ChemoCentryx Inc
        • Table Atopic Dermatitis - Pipeline by ChemoCentryx Inc,
      • ChironWells GmbH
        • Table Atopic Dermatitis - Pipeline by ChironWells GmbH,
      • Chugai Pharmaceutical Co Ltd
        • Table Atopic Dermatitis - Pipeline by Chugai Pharmaceutical Co Ltd,
      • Clevexel Pharma SA
        • Table Atopic Dermatitis - Pipeline by Clevexel Pharma SA,
      • Creabilis SA
        • Table Atopic Dermatitis - Pipeline by Creabilis SA,
      • Curapel Ltd
        • Table Atopic Dermatitis - Pipeline by Curapel Ltd,
      • Cutanea Life Sciences Inc
        • Table Atopic Dermatitis - Pipeline by Cutanea Life Sciences Inc,
      • Dermala Inc
        • Table Atopic Dermatitis - Pipeline by Dermala Inc,
      • Dr. August Wolff GmbH & Co KG Arzneimittle
        • Table Atopic Dermatitis - Pipeline by Dr. August Wolff GmbH & Co KG Arzneimittle,
      • Eli Lilly and Company
        • Table Atopic Dermatitis - Pipeline by Eli Lilly and Company,
      • F. Hoffmann-La Roche Ltd
        • Table Atopic Dermatitis - Pipeline by F. Hoffmann-La Roche Ltd,
      • Foamix Pharmaceuticals Ltd
        • Table Atopic Dermatitis - Pipeline by Foamix Pharmaceuticals Ltd,
      • Fountain Biopharma Inc
        • Table Atopic Dermatitis - Pipeline by Fountain Biopharma Inc,
      • Galapagos NV
        • Table Atopic Dermatitis - Pipeline by Galapagos NV,
      • GlaxoSmithKline Plc
        • Table Atopic Dermatitis - Pipeline by GlaxoSmithKline Plc,
      • Glenmark Pharmaceuticals Ltd
        • Table Atopic Dermatitis - Pipeline by Glenmark Pharmaceuticals Ltd,
      • Grupo Ferrer Internacional SA
        • Table Atopic Dermatitis - Pipeline by Grupo Ferrer Internacional SA,
      • Han Wha Pharma Co Ltd
        • Table Atopic Dermatitis - Pipeline by Han Wha Pharma Co Ltd,
      • HanAll Biopharma Co Ltd
        • Table Atopic Dermatitis - Pipeline by HanAll Biopharma Co Ltd,
      • Heptares Therapeutics Ltd
        • Table Atopic Dermatitis - Pipeline by Heptares Therapeutics Ltd,
      • Herantis Pharma Plc
        • Table Atopic Dermatitis - Pipeline by Herantis Pharma Plc,
      • iCo Therapeutics Inc.
        • Table Atopic Dermatitis - Pipeline by iCo Therapeutics Inc.,
      • Immune Pharmaceuticals Inc
        • Table Atopic Dermatitis - Pipeline by Immune Pharmaceuticals Inc,
      • Inflamalps SA
        • Table Atopic Dermatitis - Pipeline by Inflamalps SA,
      • Japan Tobacco Inc
        • Table Atopic Dermatitis - Pipeline by Japan Tobacco Inc,
      • Johnson & Johnson
        • Table Atopic Dermatitis - Pipeline by Johnson & Johnson,
      • Kang Stem Biotech Co Ltd
        • Table Atopic Dermatitis - Pipeline by Kang Stem Biotech Co Ltd,
      • KPI Therapeutics Inc
        • Table Atopic Dermatitis - Pipeline by KPI Therapeutics Inc,
      • LEO Pharma A/S
        • Table Atopic Dermatitis - Pipeline by LEO Pharma A/S,
      • Madam Therapeutics BV
        • Table Atopic Dermatitis - Pipeline by Madam Therapeutics BV,
      • MedImmune LLC
        • Table Atopic Dermatitis - Pipeline by MedImmune LLC,
      • Mitsubishi Tanabe Pharma Corp
        • Table Atopic Dermatitis - Pipeline by Mitsubishi Tanabe Pharma Corp,
      • NeoPharm Co Ltd
        • Table Atopic Dermatitis - Pipeline by NeoPharm Co Ltd,
      • Novan Inc
        • Table Atopic Dermatitis - Pipeline by Novan Inc,
      • Novartis AG
        • Table Atopic Dermatitis - Pipeline by Novartis AG,
      • Orbis Biosciences Inc
        • Table Atopic Dermatitis - Pipeline by Orbis Biosciences Inc,
      • Otsuka Holdings Co Ltd
        • Table Atopic Dermatitis - Pipeline by Otsuka Holdings Co Ltd,
      • Oxagen Ltd
        • Table Atopic Dermatitis - Pipeline by Oxagen Ltd,
      • Pfizer Inc
        • Table Atopic Dermatitis - Pipeline by Pfizer Inc,
      • Pharis Biotec GmbH
        • Table Atopic Dermatitis - Pipeline by Pharis Biotec GmbH,
      • Pharmedartis GmbH
        • Table Atopic Dermatitis - Pipeline by Pharmedartis GmbH,
      • Provectus Biopharmaceuticals Inc
        • Table Atopic Dermatitis - Pipeline by Provectus Biopharmaceuticals Inc,
      • PuriCore Plc
        • Table Atopic Dermatitis - Pipeline by PuriCore Plc,
      • Regeneron Pharmaceuticals Inc
        • Table Atopic Dermatitis - Pipeline by Regeneron Pharmaceuticals Inc,
      • Roivant Sciences Ltd
        • Table Atopic Dermatitis - Pipeline by Roivant Sciences Ltd,
      • Signum Dermalogix Inc
        • Table Atopic Dermatitis - Pipeline by Signum Dermalogix Inc,
      • Spherium Biomed SL
        • Table Atopic Dermatitis - Pipeline by Spherium Biomed SL,
      • sterna biologicals Gmbh & Co KG
        • Table Atopic Dermatitis - Pipeline by sterna biologicals Gmbh & Co KG,
      • Sucampo Pharmaceuticals Inc
        • Table Atopic Dermatitis - Pipeline by Sucampo Pharmaceuticals Inc,
      • Sun Pharma Advanced Research Company Ltd
        • Table Atopic Dermatitis - Pipeline by Sun Pharma Advanced Research Company Ltd,
      • SWITCH Biotech LLC
        • Table Atopic Dermatitis - Pipeline by SWITCH Biotech LLC,
      • Takeda Pharmaceutical Company Ltd
        • Table Atopic Dermatitis - Pipeline by Takeda Pharmaceutical Company Ltd,
      • Thesan Pharmaceuticals Inc
        • Table Atopic Dermatitis - Pipeline by Thesan Pharmaceuticals Inc,
      • Torrent Pharmaceuticals Ltd
        • Table Atopic Dermatitis - Pipeline by Torrent Pharmaceuticals Ltd,
      • Trevi Therapeutics Inc
        • Table Atopic Dermatitis - Pipeline by Trevi Therapeutics Inc,
      • Valeant Pharmaceuticals International Inc
        • Table Atopic Dermatitis - Pipeline by Valeant Pharmaceuticals International Inc,
      • Vicore Pharma AB
        • Table Atopic Dermatitis - Pipeline by Vicore Pharma AB,
      • Vitae Pharmaceuticals Inc
        • Table Atopic Dermatitis - Pipeline by Vitae Pharmaceuticals Inc,
      • VivaCell Biotechnology Espana SL
        • Table Atopic Dermatitis - Pipeline by VivaCell Biotechnology Espana SL,
      • Xencor Inc
        • Table Atopic Dermatitis - Pipeline by Xencor Inc,
      • Ziarco Pharma Ltd
        • Table Atopic Dermatitis - Pipeline by Ziarco Pharma Ltd
  • Therapeutics Assessment
    • Acne Vulgaris
      • Assessment by Monotherapy Products
        • Table Figure 22: Assessment by Monotherapy Products
        • Table Assessment by Monotherapy Products
      • Assessment by Combination Products
        • Table Figure 23: Assessment by Combination Products
        • Table Assessment by Combination Products
      • Assessment by Target
        • Table Figure 24: Number of Products by Top 10 Targets - Acne Vulgaris
        • Table Figure 25: Number of Products by Stage and Top 10 Targets - Acne Vulgaris
        • Table Number of Products by Stage and Target - Acne Vulgaris
      • Assessment by Mechanism of Action
        • Table Figure 26: Number of Products by Top 10 Mechanism of Actions - Acne Vulgaris
        • Table Figure 27: Number of Products by Stage and Top 10 Mechanism of Actions - Acne Vulgaris
        • Table Number of Products by Stage and Mechanism of Action
      • Assessment by Route of Administration
        • Table Figure 28: Number of Products by Routes of Administration
        • Table Figure 29: Number of Products by Stage and Routes of Administration
        • Table Number of Products by Stage and Route of Administration - Acne Vulgaris
      • Assessment by Molecule Type
        • Table Figure 30: Number of Products by Molecule Types - Acne Vulgaris
        • Table Figure 31: Number of Products by Stage and Molecule Types - Acne Vulgaris
        • Table Number of Products by Stage and Molecule Type - Acne Vulgaris
    • Psoriasis
      • Assessment by Monotherapy Products
        • Table Figure 32: Assessment by Monotherapy Products – Psoriasis
        • Table Assessment by Monotherapy Products - Psoriasis
      • Assessment by Combination Products
        • Table Figure 33: Assessment by Combination Products – Psoriasis
        • Table Assessment by Combination Products - Psoriasis
      • Assessment by Target
        • Table Figure 34: Number of Products by Top 10 Targets – Psoriasis
        • Table Figure 35: Number of Products by Stage and Top 10 Targets – Psoriasis
        • Table Number of Products by Stage and Target - Psoriasis
      • Assessment by Mechanism of Action
        • Table Figure 36: Number of Products by Top 10 Mechanism of Actions – Psoriasis
        • Table Figure 37: Number of Products by Stage and Top 10 Mechanism of Actions – Psoriasis
        • Table Number of Products by Stage and Mechanism of Action - Psoriasis
      • Assessment by Route of Administration
        • Table Figure 38: Number of Products by Top 10 Routes of Administration – Psoriasis
        • Table Figure 39: Number of Products by Stage and Top 10 Routes of Administration – Psoriasis
        • Table Number of Products by Stage and Route of Administration - Psoriasis
      • Assessment by Molecule Type
        • Table Figure 40: Number of Products by Top 10 Molecule Types – Psoriasis
        • Table Figure 41: Number of Products by Stage and Top 10 Molecule Types – Psoriasis
        • Table Number of Products by Stage and Molecule Type - Psoriasis
    • Atopic Dermatitis
      • Assessment by Monotherapy Products
        • Table Figure 42: Assessment by Monotherapy Products - Atopic Dermatitis
        • Table Assessment by Monotherapy Products - Atopic Dermatitis
      • Assessment by Target
        • Table Figure 43: Number of Products by Top 10 Targets - Atopic Dermatitis
        • Table Figure 44: Number of Products by Stage and Top 10 Targets - Atopic Dermatitis
        • Table Number of Products by Stage and Target - Atopic Dermatitis
      • Assessment by Mechanism of Action
        • Table Figure 45: Number of Products by Top 10 Mechanism of Actions - Atopic Dermatitis
        • Table Figure 46: Number of Products by Stage and Top 10 Mechanism of Actions - Atopic Dermatitis
        • Table Number of Products by Stage and Mechanism of Action - Atopic Dermatitis
      • Assessment by Route of Administration
        • Table Figure 47: Number of Products by Top 10 Routes of Administration - Atopic Dermatitis
        • Table Figure 48: Number of Products by Stage and Top 10 Routes of Administration,
        • Table Number of Products by Stage and Route of Administration - Atopic Dermatitis
      • Assessment by Molecule Type
        • Table Figure 49: Number of Products by Top 10 Molecule Types - Atopic Dermatitis
        • Table Figure 50: Number of Products by Stage and Top 10 Molecule Types - Atopic Dermatitis
        • Table Number of Products by Stage and Molecule Type - Atopic Dermatitis
  • Dormant Projects
    • Acne Vulgaris
      • Table Acne Vulgaris - Dormant Projects
    • Psoriasis
      • Table Psoriasis - Dormant Projects
    • Atopic Dermatitis
      • Table Atopic Dermatitis - Dormant Projects
  • Discontinued Products
    • Acne Vulgaris
      • Table Acne Vulgaris - Discontinued Products,
    • Psoriasis
      • Table Psoriasis - Discontinued Products,
    • Atopic Dermatitis
      • Table Atopic Dermatitis - Discontinued Products,
  • Product Development Milestones
    • Acne Vulgaris
      • Featured News & Press Releases
      • Nov 28, 2016: Foamix Announces Completion of Patient Enrollment in Phase 3 Acne Trials for Minocycline Foam FMX101
      • Nov 10, 2016: BioPharmX Presents BPX-01 Topical Minocycline Gel Acne Data at SDEFs 17th Annual Las Vegas Dermatology Seminar
      • Oct 31, 2016: Vyome Biosciences Administers First In-human Dose of VB 1953 in U.S. Phase 1 Clinical Study in Patients with Facial Acne Vulgaris
      • Oct 21, 2016: Dermira Presents Data from DRM01 Phase 2b Clinical Program at Annual Meeting for Dermatologists
      • Oct 18, 2016: Cassiopea announces completion of Phase II proof of concept of its novel antibiotic for acne and decision to pursue further development
      • Oct 18, 2016: Novan to Present Data from SB204 Phase 2b Trial at Fall Clinical Dermatology Conference
      • Oct 13, 2016: Dermira to Present Data from DRM01 Clinical Programs at Fall Clinical Dermatology Conference
      • Sep 28, 2016: Novan Announces Both SB204 Phase 3 Pivotal Trials Fully Enrolled
      • Aug 24, 2016: BioPharmX Enrolls First Subject in OPAL Phase 2b Clinical Trial of BPX-01 Topical Minocycline for the Treatment of Acne
      • Aug 22, 2016: BioPharmX Announces Final Phase 2a Trial Results Find BPX-01 Reduces Facial P. Acnes by More than 90% in Four Weeks
      • Jul 21, 2016: BioPharmX Study Shows BPX-01 Topical Gel Delivers Minocycline Precisely to the Skin
      • Jun 29, 2016: BioPharmX Announces Positive Topline Phase 2a Clinical Trial Results for BPX-01 in Patients with Acne-Causing Bacteria
      • Jun 08, 2016: Xenon Pharmaceuticals Presents Corporate Update and Highlights Its Proprietary Therapeutic XEN801 Program at the Jefferies 2016 Healthcare Conference
      • May 11, 2016: Dermira to Present Preclinical Data from DRM01 Acne Program at the Society for Investigative Dermatology 75th Annual Meeting
    • Psoriasis
      • Featured News & Press Releases
      • Nov 25, 2016: Janssen Submits Application to EMA Seeking Approval of Anti-Interleukin-23 Monoclonal Antibody Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis
      • Nov 18, 2016: Innovative Study with Three Treatment Switches Confirms Sandoz biosimilar Etanercept has Equivalent Efficacy to Originator
      • Nov 17, 2016: Janssen Submits Application To FDA Seeking Approval Of Anti-Interleukin-23 Monoclonal Antibody Guselkumab For The Treatment Of Moderate To Severe Plaque Psoriasis
      • Nov 16, 2016: Novan Announces Preclinical Data Demonstrating Immunomodulatory Effect In Vivo
      • Nov 16, 2016: Samumed Presents Data for Potential Topical Treatment for Psoriasis
      • Nov 14, 2016: Oncobiologics Announces Presentation of Final Data from Phase 1 Clinical Study of ONS-3010 (HUMIRA Biosimilar)
      • Nov 14, 2016: Novartis presents new Cosentyx data showing long-lasting efficacy in psoriatic arthritis over 3 years including patient-reported pain
      • Nov 07, 2016: Amgen To Present Data On AMJEVITA At ACR/ARHP 2016 Annual Meeting
      • Nov 03, 2016: Janssen To Present Data on Guselkumab (Anti-IL23 mAb) At The 2016 American College Of Rheumatology Meeting
      • Nov 01, 2016: Samumed to present data on SM-04755 at American College of Rheumatology 2016 Annual Meeting
      • Oct 31, 2016: Cellceutix Begins Phase 2b Clinical Trial of Oral Prurisol in Moderate-to-Severe Chronic Plaque Psoriasis
      • Oct 31, 2016: Novartis Wins Prestigious Prix Galien Foundation Award, Cosentyx as Best Biotechnology Product
      • Oct 20, 2016: Oral OTEZLA (Apremilast) Receives Positive Nice Recommendation for Adults with Chronic Plaque Psoriasis
    • Atopic Dermatitis
      • Featured News & Press Releases
      • Nov 16, 2016: PuriCore provides update on key development program PR022
      • Nov 07, 2016: New Drug Clears Atopic Dermatitis in Clinical Trials
      • Oct 03, 2016: AnaptysBio Reports ANB020 Top-Line Phase 1 Clinical Trial Results
      • Oct 01, 2016: Regeneron and Sanofi Announce Positive Dupixent (dupilumab) Phase 3 Atopic Dermatitis Data Published in the New England Journal of Medicine
      • Sep 29, 2016: MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis
      • Sep 27, 2016: Spherium Biomed starts efficacy trial Cyclatop for the treatment of atopic dermatitis in adults and infants
      • Sep 26, 2016: Regeneron and Sanofi Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA
      • Aug 17, 2016: PuriCore Receives Two U.S. Patents Covering Drug Development in Inflammatory Skin Diseases
      • Jul 13, 2016: Pfizer Announces the Publication of Final Results from Two Pivotal Phase 3 Studies of Crisaborole Topical Ointment in Patients with Mild to Moderate Atopic Dermatitis
      • Jul 06, 2016: AnaptysBio Initiates Multiple Ascending Dose Cohorts In ANB020 Phase 1 Clinical Trial
      • Jul 05, 2016: AnGes Announces Top-Line Results for Japanese Phase III Clinical Trial of NF-B Decoy Oligonucleotide for Atopic Dermatitis
      • Jun 13, 2016: Ziarco reports positive Phase 2a study results with ZPL-389 in moderate to severe atopic dermatitis patients
      • Jun 09, 2016: PuriCore successfully completes Pre-IND Meeting with the FDA on PR022 for Atopic Dermatitis
      • Jun 06, 2016: Sanofi and Regeneron Announce that Dupilumab Used with Topical Corticosteroids was Superior to Treatment with TCS Alone in Long-term Phase 3 Trial in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report